Mark E. Sims
CIK: 0002139479
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CADL
Candel Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
About Sims Mark E.
Sims Mark E. (SEC CIK 0002139479) files insider reports with the SEC as Chief Commercial Officer of Candel Therapeutics, Inc. (CADL).
Signal8 holds 2 ownership filings by Sims Mark E. (1 Form 3, 1 Form 4), filed on Jul 8, 2026. Those filings report 1 transaction, the latest on Jul 6, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Sims Mark E.'s filings is in NEEDHAM, MA.
Recent filings by Sims Mark E.
- Jul 6, 2026: Grant or award of CADL derivative securities (Form 4, code A).
Other insiders filing for Candel Therapeutics, Inc. (CADL)
- Loggia Nicoletta, Director
- PAPA JOSEPH C, Director
- Manning Paul B, Director
- Tak Paul Peter, Chief Executive Officer
- Zimmermann Martine, Director
- Tyagarajan Seshu, Chief Technology Officer